Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2022
COVID-19-associated mucormycosis: A review of an emergent epidemic fungal infection in the era of COVID-19 pandemic.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chamola Vinay, Mohammadi Rasoul, Nair Harish, Goyal Adit, Patel Aarya, Hassija Vikas, Bassetti Matteo, Narang Pratik, Paredes Roger, Santos Jose R, Hashemi Seyed Jamal, Sani Mahnaz Pejman, Shirani Kiana, Alijani Neda, Naeini Bahareh Abtahi, Pourazizi Mohsen, Abtahi Seyed Hamidreza, Khorvash Farzin, Khanjari Mahdi, Ahmadikia Kazem
Аннотация
At a time when the COVID-19's second wave is still picking up in countries like India, a number of reports describe the potential association with a rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.